Skip to main content

Table 2 Bronchoscopy characteristics

From: Sequential broncho-alveolar lavages reflect distinct pulmonary compartments: clinical and research implications in lung transplantation

   Sub-cohorts used for:
Main cohort
N = 126*
CCSP & SP-D
N = 20*
Inflammatory proteins
N = 15*
Cell count
N = 6*
Median time from transplant to bronchoscopy, days, Median (IQR) 279 (99.5–553) 189 (95–316) 196 (67.5–285) 189 (93.8–280.5)
Indication for bronchoscopy
 Surveillance 104 (82.5%) 15 (75%) 11 (73.3%) 5 (83.3%)
 Diagnostic 22 (17.5%) 5 (25%) 4 (26.7%) 1 (16.7%)
BAL localization
 RUL 5 (4%) 2 (10%) 1 (6.7%) 0
 RML 103 (81.7%) 15 (75%) 11 (73.3%) 4 (66.7%)
 RLL 4 (3.2%) 1 (5%) 1 (6.7%) 1 (16.7%)
 LUL 8 (6.3%) 2 (10%) 1 (6.7%) 1 (16.7%)
 LLL 2 (1.6%) 0 1 (6.7%) 0
 Missing records 4 (3.2%) 0 0 0
FEV1 at the time of bronchoscopy, L (Median, IQR) 2.2 (1.6–2.8) 2 (1.7–3.1) 2 (1.8–2.25) 2 (1.8–2.4)
Presence of clinically-relevant pathogen, number 29 (23%) 6 (30%) 2 (13.3%) 1 (16.7%)
AR grade
 AX 15 (11.9%) 4 (20%) 1 (6.7%) 2 (33.3%)
 A0 76 (60.3%) 13 (65%) 9 (60%) 4 (66.7%)
 A1 22 (17.5%) 3 (15%) 4 (26.7%) 0
  ≥ A2 0 0 0 0
 Biopsy not done 13 (10.3%) 0 1 (6.7%) 0
  1. AR=Acute rejection; N=number; %=percent of samples
  2. *N represents the number of bronchoscopies